US Patent Ser No 9,585,867
Press Release- September 8, 2024
Press Release- September 8, 2024
West Palm Beach, FL
NON-LETHAL WEAPONIZED CANNABIS ™
Donated To The Public Domain
My name is Charles Ankner, and I’m the founder and senior steward of SAINT™ BRAND CANNABIS, and owner of US Pat Ser No 9,585,867 which protects a method of sedating a person or animal from a distance via an inventive ballistic dart and inventive cannabinoid sedation formulation.
From the patent:
“Advantageously, a humane cannabinoid formulation may be used as and for quickly and safely sedating a subject within a short period of time, thus making subduing, and if required, containing the subject safer for all involved.
Additionally, and depending upon the cannabinoid formulation, a human or animal may be quickly incapacitated or immobilized at a distance. The purpose of and for incapacitating or immobilizing a human or animal may be many and varied. It is contemplated that the fields of medicine, veterinary medicine and science, military combat, law enforcement, corrections, emergency response, mass casualty response, and similar fields of endeavor may benefit from cannabinoid sedative formulations, or a cannabinoid being added to or administered with known sedative formulations for medical, scientific, and industrial purposes. Other cannabinoid sedative formulations may be also used for scientific and industrial use improvement and purposes.
Advantageously however, CB1 receptors are absent in the medulla oblongata, the part of the brain stem responsible for autonomic respiratory and cardiovascular function. This is highly advantageous when cannabinoids are used for and as sedative and anesthetic formulations. Affecting or depressing autonomic respiratory and/or cardiovascular function has long been a limiting disadvantage of known sedative and anesthetic formulations. Fortunately, unless introduced at extremely toxic levels, CB1 agonist cannabinoids primarily leave autonomic respiratory and cardiovascular functions in humans and animals unaffected, due to the lack of CB1 receptors in the brain stem medulla oblongata.”
The broadest claim:
8. A method of humanely incapacitating or immobilizing a human or animal comprising:
providing a formulation including a cannabinoid;
providing a delivery system comprising an injection step capable of dosing the recipient with the formulation at a distance which renders a recipient incapacitated or immobilized within a short period of time after dosing, and
wherein the recipient remains incapacitated or immobilized for a long period of time-after dosing without irreparable harm to or the death of the recipient; and
immobilizing the recipient by using the delivery system to dose the recipient with said formulation.
This was my first “personal” patent granted; filed in 2015, granted in 2017, and if maintained set for expiration in 2035.
For a few reasons; I’ve decided to allow the patent lapse and fall into the public domain.
First, I was a bit before my time. Cannabis has remained a Class I Controlled Substance. I was not under any delusion that I could personally bring “such a thing” to market; although my private R&D was extensive.
I had approached several pharmaceutical companies exploring purchase of the patent and/or a strategic alliance to further develop the formulation - no dice. Under present cannabis prohibition; darting/injecting someone at a distance with NON-LETHAL WEAPONIZED CANNABIS™ …was an idea whose time had just not yet come.
Second, the “patent family remains alive” with my US Pat App Ser No 17/494,469 (heading to Appeal), and two other “strategically abandoned” applications, US 15/399,428 and 15/412,211.
I plan to “pick those back up again” within a few years and hopefully after government overreach related to cannabis is a thing of the past, file new CIP applications.
Third, by allowing the invention to enter the public domain, anyone globally may now develop the technology further. Modern methods are just now beginning to be applied to cannabis related scientific, medical, and industrial endeavors.
The more I study and invent related to cannabis and cannabinoids; the more convinced I am that the benefits of “this weed” will greatly mitigate the pain and suffering which plagues the present “human condition”.
My prayer is that those with the wherewithal will further develop injectable cannabinoid formulations for various benevolent and beneficial objectives and outcomes. Grant this O’ Lord.
Sincerely and respectfully,
Charles Ankner,
Web: www.SaintBrandCannabis.com
Email: charles@saintbrandcannabis.com
Tel in US: 805.598.3422
Copyright © 2024 Charles Ankner Social Enterprises, LLC.